OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
Laurette van Boheemen, Marian H. van Beers-Tas, Johanna M. Kroese, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237072-e0237072
Open Access | Times Cited: 16

Showing 16 citing articles:

Cardiovascular effects of approved drugs for rheumatoid arthritis
Fabiola Atzeni, Javier Rodríguez‐Carrio, Călin D. Popa, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 5, pp. 270-290
Closed Access | Times Cited: 79

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
Laurette van Boheemen, Samina A. Turk, Marian H. van Beers-Tas, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001591-e001591
Open Access | Times Cited: 61

Dyslipidemia in rheumatoid arthritis: the possible mechanisms
Jiahui Yan, Sisi Yang, Liang Han, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32

A study of lipid profile peculiarities and atherogenic index of plasma in patients younger than fifty years of age with newly diagnosed rheumatoid arthritis
Varsha Bhatt, Kavita Krishna, Vishal Asrani, et al.
Journal of Family Medicine and Primary Care (2025) Vol. 14, Iss. 1, pp. 154-159
Open Access

Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
Guangyang Zhang, Yuanqing Cai, Jialin Liang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13

Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
Arturo J Martí-Carvajal, Mario A Gemmato-Valecillos, Diana Monge Martín, et al.
Cochrane library (2024) Vol. 2024, Iss. 9
Closed Access | Times Cited: 2

The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients
Ching‐Kun Chang, En‐Pei Isabel Chiang, Kuang‐Hsi Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10645-10645
Open Access | Times Cited: 6

Cardiovascular Risk and Systemic Inflammation in Rheumatoid Arthritis: Comparative Insights with Psoriatic Arthritis
Mateusz Kęska, Wiktoria Suchy
Archives of Pharmacy Practice (2024) Vol. 15, Iss. 3, pp. 58-65
Open Access | Times Cited: 1

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
Marino Paroli, Maria Isabella Sirinian
Antibodies (2023) Vol. 12, Iss. 4, pp. 69-69
Open Access | Times Cited: 3

Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study
Reinder Raadsen, Bas Dijkshoorn, Laurette van Boheemen, et al.
Joint Bone Spine (2023) Vol. 91, Iss. 3, pp. 105683-105683
Open Access | Times Cited: 1

Interleukin-receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
Arturo J Martí-Carvajal, Juan Bautista De Sanctis, Mark Dayer, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 1

Nursing Care through ICTs in Hypertensive Teachers with Cardiovascular Risk in a Primary Care Centers
Djamila Gallegos-Espinoza, Livia Piñas-Rivera, Lucía Asencios-Trujillo, et al.
EAI Endorsed Transactions on Pervasive Health and Technology (2023) Vol. 9
Open Access

Page 1

Scroll to top